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Abstract: 
Tuberculosis is known to occur more in cases of chronic diabetes mellitus. The exact cause of such an association is mostly 
unknown. Recently we have shown using tools of computational biology that glycation of the subunits of respiratory burst enzyme 
NADPH oxidase may impair intra-macrophage killing of Mycobacterium tuberculosis. Since glycation of proteins including subunits 
of NADPH oxidase will be significantly increased in long standing uncontrolled diabetes we have concluded that it may be an 
important factor for increased association of tuberculosis in diabetic state. Analogous to NADPH oxidase, role of NOS is proved 
beyond any doubt for killing of intracellular pathogen like Mycobacterium tuberculosis. Based on the above mentioned premises, in 
this work we have studied glycation of various domains of iNOS using tools of computational biology and observed that glycation 
of K531 of   Calmodulin binding domain of iNOS may impair the enzyme activity. We have concluded that the above phenomenon 
can happen at chronic diabetic state which may render the host susceptible to tuberculosis. 
 
Key Words: Diabetes mellitus; tuberculosis, NOS, reactive oxygen species, reactive nitrogen species, glycation. 
 
 
 
 
 
Background: 
Mycobacterium tuberculosis is an intracellular pathogen. After 
entering into the body it goes inside the macrophages by the 
process of phagocytosis. Unlike many pathogens it does not 
allow a very successful fusion of the phagosome with lysosome 
of the macrophage and stays inside the stable phagosome. It 
also inhibits the respiratory burst activity of the phagosome to a 
large extent reducing generation of reactive oxygen species 
(ROS) inside the phagosome. All these facts have made it a very 
competent pathogen infecting almost one third of the world 
population [1].  
 
Analogous to ROS, nitric oxide synthase (NOS) derived reactive 
nitrogen species (RNS) plays important role in killing of 
intracellular bacteria. Mycobacterium tuberculosis is also not an 
exception in this regard. NOS has three isoforms namely 
inducible NOS, endothelial NOS and neuronal NOS popularly 
known as iNOS, eNOS and nNOS, respectively [2]. Of these 
particularly iNOS is expressed in macrophages and plays 
important role for killing of intracellular pathogens including 
Mycobacterium tuberculosis [3]. 
 
Diabetes mellitus is an epidemic of the modern world. It is 
characterized by persistent hyperglycemia due to relative or 
absolute deficiency of insulin. Long standing diabetes with 
uncontrolled hyperglycemia is known to cause increased non-
enzymatic glycation of proteins. It is also known to be 
associated with increased occurrence of tuberculosis. There is 
evidence to believe that increased association of tuberculosis in 
chronic uncontrolled diabetes is directly correlated with the 
extent of protein glycation. In this context the consequence of BIOINFORMATION  open access 
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glycation on NADPH oxidase activity is investigated earlier 
using tools of computational biology and it is observed that 
there is possibility of glycation induced inhibition of the 
enzyme activity. This in silico observation, if proved to be a fact 
experimentally, can serve as an explanation for increased 
association of tuberculosis in diabetic state [4].  
 
In similar ways there may be glycation induced inhibition of 
NOS. In this work we have developed this hypothesis using 
tools of computational biology. Glycation induced inhibition of 
NOS may reduce generation of RNS and thus rendering a 
diabetic host more susceptible to tuberculosis.  
 
Methodology: 
Three isoforms of NOS proteins in human – iNOS, nNOS and 
eNOS are taken into consideration. The sequences are taken 
from UniProtKB database [5]. The accession numbers for the 
proteins are as follows – iNOS: P35228; nNOS: P29475; eNOS: 
P29474. Sequence and domain annotations of all the isoforms 
are noted from corresponding uniprot id database [6-8]. The 
complex structures of calmodulin and calmodulin binding 
region of NOS proteins are taken from Protein Data Bank (PDB) 
[9] having PDB code - iNOS: 3HR4 [10], nNOS: 2O60 [11] and 
eNOS: 1NIW [12], respectively. The glycation of the ε amino 
group of lysine (Lys) residues are predicted using NetGlycate 
1.0 server [13]. Molecular diagrams are drawn using pymol [14]. 
 
 
Figure 1: Interaction between calmodulin and calmodulin 
binding peptide region of NOS proteins (in 1a-iNOS, 1b-nNOS 
and 1c-eNOS, respectively) through predicted glycated lysine 
residue of calmodulin binding region of NOS proteins are 
depicted. Both calmodulin and calmodulin binding region of 
NOS proteins are shown in ribbon diagram with calmodulin in 
green and NOS proteins in blue colour. The Ca+2 ions are 
represented as green spheres. The lysine residues of calmodulin 
and interacting partner residues of NOS proteins are shown in 
stick mode with carbon, nitrogen and oxygen atoms in green, 
blue and red colour, respectively. The interaction between the 
atoms is shown by yellow dashed lines with distance in Å. All 
residues are labeled by one letter amino acid code with residue 
number obtained from corresponding PDB file.  
 
Results and Discussion: 
Domain classification of all the three isoforms of NOS proteins 
are given in (Table 1, see supplementary material). It is 
observed that the total number of residues is varied but the 
domain architectures are similar in all the three isoforms. The 
lysine residues of each domain which are predicted to be 
glycated are also mentioned in Table 1 (see supplementary 
material) NO production is regulated by interdomain 
interaction between NOS and calmodulin [10]. S o  w e  h a v e  
analyzed all the complex structures of calmodulin and NOS 
proteins obtained from PDB. Calmodulin binding region of 
NOS proteins have lysine residue which is predicted to be 
glycated in all the three isoforms (Table 1, see supplementary 
material). Upon manual visualization of the complex structures, 
it is found that the predicted glycated lysine residue K531 is 
making salt bridge with acidic residue E54 (distance 2.89 Å) in 
iNOS-calmodulin complex (Figure 1a). Further, E54 is 
important residue for making the EF-hand loop that coordinates 
Ca+2 ions. So, if K531 becomes glycated, the ε amino group is 
n o t  e x p e c t e d  t o  f o r m  s a l t  b r i d g e  w i t h  p a r t n e r  r e s i d u e  o f  
calmodulin. In such a situation the coordination to Ca2+ ion will 
be blocked due to improper conformation of the EF-hand loop. 
Furthermore, if EF-hand loop is not properly formed, it will also 
weaken   the interaction between iNOS and calmodulim. In case 
of nNOS-calmodulin complex the predicted glycated lysine 
residue K737 is interacting with polar group (peptide oxygen 
atom) of M145 and A147 (Figure 1b). However, the distances 
are higher (3.49 Å and 4.45 Å, respectively) than the distance in 
iNOS-calmodulin complex (2.89 Å). Further, neither of these 
two residues is coordinating to Ca2+ i o n .  I n  c a s e  o f  e N O S -
calmodulin complex the predicted glycated lysine residue K497 
is interacting with acidic residue E7 with two carboxylate 
oxygen atoms at distances 3.31 Å and 4.35 Å, respectively 
(Figure 1c). Here also, this E7 is not coordinating to Ca+2 ion. So 
if the lysine residues (K737 and K497) of nNOS and eNOS 
become glycated, the interaction between calmodulin and NOS 
may not be affected when compared to iNOS. In these cases the 
coordination to the Ca+2 ions is not expected be affected.  
 
Calmodulin binding to NOS is universally required for its 
functional activity and in case of iNOS the Calmodulin binding 
may be an effective stimulator of the enzyme irrespective of the 
availability of the calcium ion [10, 15]. It is in this context our in-
silico observation is important. We have found that glycation of 
Lys531 in the Calmodulin binding domain of iNOS is causing a 
structural change in the molecular microenvironment that is not 
suitable for Ca+2 and Calmodulin binding. Although Lys737 
and Lys497 are glycated in the other two isoforms of NOS, the 
possibility of glycation induced inhibition of Calmodulin (or 
Ca+2) binding is less apparent in the other two isoforms. 
Therefore possibility of Lys737 and Lys497 glycation induced 
inhibition of Calmodulin binding is comparitively less in nNOS 
and eNOS, respectively when compared to iNOS. Glycation is 
practically more possible in macrophages compared to other 
cells or its precursors since glucose transporters are expressed 
more on the mature macrophage membrane that is expected to 
transport more glucose inside the macrophage from extra-
cellular environment particularly at hyperglycemic state [16]. 
At the present moment there are experimental evidences to 
support this idea [17]. Therefore in persistent hyperglycemia 
p r o t e i n s  l i k e  i N O S  t h a t  r e s i d e  i n s i d e  t h e  m a c r o p h a g e  a r e  
expected to be glycated more which has the potential to inhibit BIOINFORMATION  open access 
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Calmodulin-iNOS interaction. A vast literature is in the favor of 
absolute requirement of Calmodulin binding for functioning of 
iNOS [18].  
 
Therefore, if such in silico observation proves to be 
experimentally true there is enough chance of glycation 
induced inhibition of iNOS activity. It is needless to explain that 
glycation induced inhibition of iNOS will make the chronic 
diabetic host more susceptible to tuberculosis. It is also known 
that reactive nitrogen species (RNS) play an essential role in 
host defense against Mycobacterium tuberculosis in the mouse 
model of tuberculosis as evidenced by the increased 
susceptibility of mice deficient in the inducible isoform of nitric 
oxide synthase (iNOS) [19].  This fact makes it almost evident 
th at if inhibiti on of iNOS ha ppe ns due  to a ny re ason, it w ill  
make the host more susceptible to tuberculosis. Since glycation 
is the hallmark of chronic uncontrolled diabetes, glycation 
induced inhibition of iNOS can be considered as a cause of 
increased association of tuberculosis in diabetic state. In this 
connection it is worth mentioning that in diabetic state 
endogenous inhibitors of NOS is described in the literature [20] 
and that is also thought as a link between increased incidences 
of tuberculosis in diabetic state [4].  
 
Conclusion: 
We show structural models to support that there is a high 
possibility of glycation induced inhibition of iNOS which may 
serve as a causative factor for more tuberculosis infection in 
diabetic state. It should be noted that this hypothesis should be 
validated using experimental inference. 
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Supplementary material: 
 
Table 1: Domain classification and predicted glycated lysine residues in iNOS, nNOS and eNOS. Sequence annotation is given 
according to the position of amino acid in protein sequence. 
iNOS (total residues 1153)  nNOS (total residues 1434)  eNOS (total residues 1203) 
Domain 
classification 
Predicted 
glycated 
residues 
Domain classification  Predicted glycated 
residues 
Domain 
classification 
Predicted 
glycated 
residues  Range Description  Range  Description  Range Description 
509-
529 
Calmodulin 
binding 
531K 1-205 
Interaction with 
NOSIP 
24K,38K,131K,143K 
98-
486 
Interaction 
with NOSIP 
108K, 
395K, 
397K, 
429K 
539-
677 
Flavodoxin-
like 
549K 17-99  PDZ  24K,38K 
491-
510 
Calmodulin 
binding 
497K 
623-
654 
FMN 
binding 
 
163-
245 
PIN binding  207K 
520-
703 
Flavodoxin-
like 
544K, 
610K, 
631K 
730-
970 
FAD 
binding FR-
type 
730K,738K,872K 
730-
750 
Calmodulin binding  737K 
649-
680 
FMN 
binding 
 
767-
778 
FAD 
binding 
 
755-
774 
Tetrahydrobiopterin 
binding 
759K 
756-
1002 
FAD 
binding FR-
type 
773K 
903-
913 
FAD 
binding 
 
760-
940 
Flavodoxin-like  776K, 847K, 861K 
793-
804 
FAD 
binding 
 
978-
996 
NADP 
binding 
 
886-
917 
FMN binding   
935-
945 
FAD 
binding 
 
1076-
1091 
NADP 
binding 
 
995-
1242 
FAD binding FR-
type 
1012K, 1160K, 
1127K 
1010-
1028 
NADP 
binding 
 
    
1032-
1043 
FAD binding   
1108-
1123 
NADP 
binding 
 
    
1175-
1185 
FAD binding         
    
1250-
1268 
NADP binding         
    
1348-
1363 
NADP binding         
 
 
 
 
 
 
 